Cargando…
Ceramide Kinase (CERK) Emerges as a Common Therapeutic Target for Triple Positive and Triple Negative Breast Cancer Cells
SIMPLE SUMMARY: Existing chemotherapy treatments for breast cancer patients are high on toxicity. There are very limited options available for triple-positive breast cancer (TPBC) patients, and there have not been any major breakthrough for targeted therapy for triple-negative breast cancer (TNBC) p...
Autores principales: | Rajput, Kajal, Ansari, Mohammad Nafees, Jha, Somesh K., Pani, Trishna, Medatwal, Nihal, Chattopadhyay, Somdeb, Bajaj, Avinash, Dasgupta, Ujjaini |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9497187/ https://www.ncbi.nlm.nih.gov/pubmed/36139656 http://dx.doi.org/10.3390/cancers14184496 |
Ejemplares similares
-
Alternative splicing of ceramide synthase 2 alters levels of specific ceramides and modulates cancer cell proliferation and migration in Luminal B breast cancer subtype
por: Pani, Trishna, et al.
Publicado: (2021) -
Alternative splicing of CERS2 promotes cell proliferation and migration in luminal B subtype breast cancer cells
por: Pani, Trishna, et al.
Publicado: (2021) -
A localized hydrogel-mediated chemotherapy causes immunogenic cell death via activation of ceramide-mediated unfolded protein response
por: Kar, Animesh, et al.
Publicado: (2023) -
Sorbitol Reduces Sensitivity to Alternaria by Promoting Ceramide Kinases (CERK) Expression through Transcription Factor Pswrky25 in Populus (Populus simonii Carr.)
por: Qi, Meng, et al.
Publicado: (2022) -
A Localized Chimeric Hydrogel Therapy Combats Tumor
Progression through Alteration of Sphingolipid Metabolism
por: Pal, Sanjay, et al.
Publicado: (2019)